You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Hematologic malignancies

Showing 1 - 25 of 4,096
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Relmacabtagene Autoleucel in Hematologic Malignancies

Not yet recruiting
  • Lymphoma, B-Cell
  • +2 more
  • Relmacabtagene Autoleucel
  • Beijing, Beijing, China
  • +1 more
Nov 15, 2023

Hematologic Malignancies Trial in Zhengzhou (RD13-02 cell infusion)

Recruiting
  • Hematologic Malignancies
  • RD13-02 cell infusion
  • Zhengzhou, Henan, China
    Henan Cancer Hospital
Jun 26, 2023

Acute Myeloid Leukemia, B-cell Acute Lymphoblastic Leukemia, High-risk Myelodysplastic Syndrome Trial (VIP943)

Not yet recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • (no location specified)
Sep 5, 2023

Chronic Lymphocytic Leukemia (CLL), Diffuse Large B-cell Lymphoma (DLBCL), Follicular Lymphoma (FL) Trial (Routine care as per

Not yet recruiting
  • Chronic Lymphocytic Leukemia (CLL)
  • +5 more
  • Routine care as per site standard.
  • (no location specified)
Sep 15, 2023

Non-hodgkin Lymphoma, Acute Lymphoblastic Leukaemia, Chronic Lymphocytic Leukemia Trial in Tianjin (CC312)

Recruiting
  • Non-hodgkin Lymphoma
  • +2 more
  • CC312
  • Tianjin, Tianjin, China
    InstituteHBDH
Sep 12, 2023

Hematologic Malignancies Trial in Assiut (CD56)

Recruiting
  • Hematologic Malignancies
  • CD56
  • Assiut, Egypt
  • +1 more
Jul 20, 2022

Hematologic Malignancy, Blood Cancer, Lymphoma Trial in Boston (Palliative Care, Usual Care)

Recruiting
  • Hematologic Malignancy
  • +4 more
  • Palliative Care
  • Usual Care
  • Boston, Massachusetts
    Massachusetts General Hospital Cancer Center
Jan 24, 2023

Advanced Systemic Mastocytosis Trial (BLU-263, Azacitidine)

Not yet recruiting
  • Advanced Systemic Mastocytosis
  • (no location specified)
Nov 2, 2022

Hematologic Tumors Trial run by the NCI (donor lymphocyte infusion, Cyclophosphamide, Busulfan)

Suspended
  • Hematologic Neoplasms
  • donor lymphocyte infusion
  • +5 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Nov 30, 2022

Hematologic Tumors, Neutropenia, Anemia Trial in Wuhan (umbilical cord derived mesenchymal stem cells)

Not yet recruiting
  • Hematologic Neoplasms
  • +5 more
  • umbilical cord derived mesenchymal stem cells
  • Wuhan, Hubei, China
  • +2 more
Jan 3, 2023

Hematopoietic Stem Cell Transplantation, Hematologic Malignancy Trial (CliniMACS®)

Not yet recruiting
  • Hematopoietic Stem Cell Transplantation
  • Hematologic Malignancy
  • CliniMACS®
  • (no location specified)
Oct 17, 2023

Multiple Myeloma, Amyloidosis, Plasma Cell Leukemia Trial in Birmingham

Recruiting
  • Multiple Myeloma
  • +2 more
    • Birmingham, Alabama
      Kirklin Clinic of UAB Hospital
    Sep 22, 2022

    Acute Lymphoblastic Leukemia, B-cell Lymphoma, Chronic Lymphocytic Leukemia Trial in Xuzhou (allogenic CD19-CAR-NK cells)

    Recruiting
    • Acute Lymphoblastic Leukemia
    • +2 more
    • allogenic CD19-CAR-NK cells
    • Xuzhou, Jiangsu, China
      The Affiliated Hospital of Xuzhou Medical University
    Feb 11, 2023

    Aggressive B-Cell Non-Hodgkin's Lymphoma, Aggressive B-Cell NHL, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Trial

    Not yet recruiting
    • Aggressive B-Cell Non-Hodgkin's Lymphoma
    • +4 more
    • (no location specified)
    Dec 16, 2022

    B-Cell Lymphoblastic Leukemia/Lymphoma Trial in Kunming (Anti-CD19 UCAR-NK cells)

    Recruiting
    • B-Cell Lymphoblastic Leukemia/Lymphoma
    • Anti-CD19 UCAR-NK cells
    • Kunming, Yunnan, China
      920th Hospital of Joint Logistics Support Force of People's Libe
    Dec 19, 2022

    Hematologic Malignancies Trial in La Jolla (Cyclophosphamide 50 mg/kg IV Days 3 and 4 post transplant)

    Suspended
    • Hematologic Malignancies
    • Cyclophosphamide 50 mg/kg IV Days 3 and 4 post transplant
    • La Jolla, California
      UCSD Medical Center
    Jul 20, 2022

    Acute Leukemia, Multiple Myeloma, Non-Hodgkin Lymphoma Trial (3D189)

    Recruiting
    • Acute Leukemia
    • +3 more
    • 3D189
    • Guangzhou, Guangdong, China
    • +3 more
    Jan 2, 2023

    Hematologic Malignancies Trial in Australia, United States (APG-2575)

    Recruiting
    • Hematologic Malignancies
    • Jacksonville, Florida
    • +4 more
    Aug 12, 2022

    Acute GVHD, Hematopoietic and Lymphoid System Tumor Trial in Duarte (Cholestyramine, Leflunomide, Steroid Therapy)

    Recruiting
    • Acute Graft Versus Host Disease
    • Hematopoietic and Lymphoid System Neoplasm
    • Duarte, California
      City of Hope Medical Center
    Jan 5, 2023

    B-cell Lymphoma, B-cell Leukemia Trial in Kunming (anti-CD19 UCAR-NK cells)

    Withdrawn
    • B-cell Lymphoma
    • B-cell Leukemia
    • anti-CD19 UCAR-NK cells
    • Kunming, Yunnan, China
      Kunming Hope of Health Hospital
    Nov 27, 2022

    Cognitive Aftereffects of Neurotoxicity in Children and Young

    Not yet recruiting
    • Lymphoma
    • Leukemia
      • Los Angeles, California
      • +2 more
      Feb 2, 2023

      Pediatric Hematologic Malignancies Trial in Saint Louis (Ex Vivo T-cell receptor alpha-beta and CD19+ Depletion using CliniMACs

      Not yet recruiting
      • Pediatric Hematologic Malignancies
      • Ex Vivo T-cell receptor alpha-beta and CD19+ Depletion using CliniMACs Plus
      • Saint Louis, Missouri
        Washington University School of Medicine
      Jul 20, 2022

      Relapsed or Refractory Hematologic Malignancies Trial in Chicago (Omacetaxine, Venetoclax)

      Recruiting
      • Relapsed or Refractory Hematologic Malignancies
      • Chicago, Illinois
        University of Illinois Cancer Center
      Sep 27, 2022

      Relapsed or Refractory B-cell Hematologic Malignancies Trial in Beijing, Nanjing (HEC89736)

      Active, not recruiting
      • Relapsed or Refractory B-cell Hematologic Malignancies
      • Beijing, Beijing, China
      • +1 more
      May 5, 2022

      Cancer Trial in Rochester (M-Tech, Usual Care)

      Not yet recruiting
      • Cancer
      • M-Tech
      • Usual Care
      • Rochester, New York
        University of Rochester
      Jul 11, 2022